290 related articles for article (PubMed ID: 20524204)
1. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
3. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
4. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
5. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
6. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
Wang N; Chen Y; Han Y; Zhao Y; Liu Y; Guo K; Jiang Y
Tumori; 2012 Nov; 98(6):783-91. PubMed ID: 23389367
[TBL] [Abstract][Full Text] [Related]
8. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
11. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
12. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
13. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling in pancreatic cancer with and without lymph node metastasis.
Cui Y; Wu J; Zong M; Song G; Jia Q; Jiang J; Han J
Int J Cancer; 2009 Apr; 124(7):1614-21. PubMed ID: 19152423
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.
Yuanming L; Lineng Z; Baorong S; Junjie P; Sanjun C
BMC Cancer; 2013 Mar; 13():103. PubMed ID: 23496813
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
17. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection.
Yao H; Zhang Z; Xiao Z; Chen Y; Li C; Zhang P; Li M; Liu Y; Guan Y; Yu Y; Chen Z
Lung Cancer; 2009 Jul; 65(1):41-8. PubMed ID: 19058872
[TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
[TBL] [Abstract][Full Text] [Related]
19. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
[TBL] [Abstract][Full Text] [Related]
20. Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes.
Zhuang A; Zhuang A; Chen Y; Qin Z; Zhu D; Ren L; Wei Y; Zhou P; Yue X; He F; Xu J; Ding C
Elife; 2023 May; 12():. PubMed ID: 37158593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
